Page last updated: 2024-11-03

proadifen and Leukemia L 1210

proadifen has been researched along with Leukemia L 1210 in 3 studies

Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HIRSCHBERG, E1
BRINDLE, SD1
SEMENTE, G1
Field, RB1
Gang, M1
Kline, I1
Venditti, JM1
Waravdekar, VS1
Hart, LG1
Adamson, RH1

Other Studies

3 other studies available for proadifen and Leukemia L 1210

ArticleYear
DEVELOPMENT AND PROPERTIES OF MOUSE LEUKEMIA L1210 RESISTANT TO MIRACIL D.
    Cancer research, 1964, Volume: 24

    Topics: Adenine; Animals; Azaguanine; Cyclophosphamide; Enzyme Inhibitors; Folic Acid; Glutamates; Guanine;

1964
The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.
    The Journal of pharmacology and experimental therapeutics, 1972, Volume: 180, Issue:2

    Topics: Animals; Biological Assay; Cyclophosphamide; Drug Interactions; Drug Synergism; Kinetics; Leukemia L

1972
Effect of microsomal enzyme modifiers on toxicity and therapeutic activity of cyclophosphamide in mice.
    Archives internationales de pharmacodynamie et de therapie, 1969, Volume: 180, Issue:2

    Topics: Animals; Cyclophosphamide; Environment; Female; Hardness; Leukemia L1210; Mice; Phenobarbital; Proad

1969